Dana-Farber Tells Fed. Circ. Not To Revisit Inventorship Ruling

Law360 (September 15, 2020, 6:08 PM EDT) -- The Dana-Farber Cancer Institute is urging the full Federal Circuit not to reconsider a panel decision requiring a pair of American scientists to be named as co-inventors on patents involved in Nobel Prize-winning cancer research.

In a brief filed Monday, Dana-Farber told the full appeals court it should keep in place a panel's July decision that Gordon Freeman and Clive Wood should be named alongside Japanese researchers as co-inventors. The panel had concluded that they made significant contributions toward discovering a protein that later spawned a new cancer treatment.

Ono Pharmaceutical Co. Ltd., which owned the patents, and licensee Bristol Myers...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!